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ABSTRACT

The effect of Monensin on clinical mastitis in dairy cattle was evaluated from data collected at
nine geographical clinical field trials using 966 Holstein cows and heifers in the United States
and Canada. At each site, a randomized complete block design was conducted. Monensin
(Rumensin®) was fed at concentrations of 0, 8, 16, or 24 ppm in a total mixed ration beginning
21 days before first calving for all nine sites, up to 7 days after second calving for six sites, and
203 days after second calving for three sites. Quarter milk samples were taken and cultured to
determine the causative pathogen for each mastitis case and if clinical signs were observed the
disease data were grouped according to etiology and analyses conducted. Analyses were
conducted for all clinical mastitis cases as well as for a breakdown of the clinical mastitis cases
into microorganism group levels.
A generalized linear mixed model and a linear mixed model were used to determine if there were
significant differences in clinical mastitis between the non-zero concentrations of Monensin and
controls. Response variables for the clinical mastitis cases that were analyzed using a
generalized linear mixed model were Animal rate, Quarter rate, Observation rate, and Incident
rate. An additional response variable, Average case duration, was analyzed using a linear mixed
model. Inferences from the analyses indicate that Monensin does not influence the susceptibility
of dairy cattle to clinical mastitis.
Key words: Monensin, Rumensin, Clinical Mastitis, Generalized Linear Mixed Model, Linear
Mixed Model, Dairy Cattle.

1. INTRODUCTION
Mastitis is generally recognized as a very costly disease to the dairy industry. It manifests itself
in lowered milk yield, increased costs of production, and reduced milk quality. Annually,
economic loss due to mastitis in the United States is estimated to be $185 per cow. If the cost
per cow is multiplied by the total number of milk cows (9.5 million head), the total annual loss of
mastitis is about $1.8 billion. Therefore, it is critical to determine the impact of any new
technology on mastitis.
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Monensin has been fed to beef cattle in United States and twenty other countries for over twenty
five years for the control of coccidiosis and the enhancement of growth performance.
Studies were conducted to determine the effect of Monensin on milk production efficiency,
health and safety in dairy cattle. Nine clinical field trials were conducted in the United States
and Canada which involved 966 Holstein cows and heifers. Efficacy data as well as health and
safety data were collected for each cow and pooled for analysis. Clinical mastitis data were
analyzed to determine if Monensin had any impact on the susceptibility of dairy cattle to clinical
mastitis.

2. MATERIALS AND METHODS
Monensin was fed to dairy cattle at concentrations of 0, 8, 16, or 24 ppm in a total mixed ration
(dry matter basis) at all nine sites, beginning approximately 21 days before anticipated calving
(Calving 1) and continuing through the following lactation and dry period, until seven days after
the next calving (Calving 2). Feeding of Monensin continued in three of the nine sites until
approximately 203 days in milk of the second lactation. Of the 966 Holstein cows and heifers
that started the study, only 372 were designated to continue in the three trial sites. Of the 372
animals, two hundred forty nine began the second lactation.

3. DATA COLLECTION AND SUMMARIZATION
Cows were checked for clinical signs of mastitis at each milking. Quarter milk samples were
collected if clinical signs were observed. Quarter milk samples collected were cultured to
determine the causative pathogen if mastitis was detected, then the pathogen was classified
according to etiology, Table 1, before being analyzed. Individual incidents (cases) and the days
over which incidents persisted were recorded for each quarter. Data were then analyzed for each
pathogen group, Table 1, as well as ignoring the pathogen classification, All Cases, Table 1, for
each of five summary periods, Table 2.

4. STATISTICAL METHODS
Animal rate, Quarter rate, Incident rate, Observation rate, and Average case duration were
analyzed at each group classification, Table 1, for each of five summary periods, Table 2.
Counts and proportions (Animal, Quarter, Observation, and Incident rates) were treated as
discrete variables, and Average case duration was treated as a continuous variable.
For the count and proportion data, a generalized linear mixed model associated with each of the
four response variables, Animal, Quarter, Observation and Incident rate, is given in Table 3. The
analyses were conducted using the GLIMMIX macro, SAS V6.12. If the criterion for using a
generalized linear mixed model was not met or if the model failed to converge, then an exact
method, Proc StatXact® v4.0 (Mehta and Patel, 1987), was conducted. If the data were too
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sparse, for instance, when both parity groups had less than three observations, then a frequency
table was created.
For the continuous response variable, Average case duration, a linear mixed model was used
(Table 4). The analysis was conducted using Proc Mixed SAS V6.12.

5. RESULTS
Results will focus on two periods of the study, Calving 30-CD and 50-CE, Table 2, at All Cases
level since 94.1% of the clinical mastitis incidents occurred during these two periods. Tables 5
and 6 show the etiology of mastitis cases by Monensin concentrations for each of the five
variables Animal rate, Quarter rate, Observation rate, Incident rate and Average case duration
during 30-CD and 50-CE, respectively.
For the 30-CD period, no Parity by Treatment interactions were detected (P > 0.25) and no
Monensin effects were detected (P > 0.10) for Animal, Quarter, Observation, or Incident rates, as
well as Average case duration (Table 5).
For the 50–CE period, Parity by Treatment interaction was detected (P = 0.01) for Average case
duration. Therefore, analyses for Average case duration were conducted for each parity.
Observation rate for clinical mastitis was lower (P < 0.10) in the 24 ppm Monensin group than
the controls (Table 6). However, there is no indication that Monensin should reduce Observation
rate in dairy cattle. No other effects were detected (P > 0.10) for either Animal, Quarter or
Incident rate. For Average case duration, primiparous cattle receiving Monensin at 8 ppm had a
longer duration than controls (P = 0.01, Table 6). This was caused by one cow from the 8 ppm
group with a case duration 320 days.

6. SUMMARY
Monensin did not adversely affect the incidence or duration of clinical mastitis across etiologies,
in either the first or second lactation of dairy cattle.
When clinical mastitis data were analyzed at All Cases level, some significant differences
between non-zero concentration of Monensin and control were detected. No significant
differences were detected for any rate or duration variable for the period 30-CD. A significant
Observation rate reduction for the 24 ppm Monensin group, and a significant longer Average
case duration for the 8 ppm Monensin group were detected when compared to control for the
period, 50-CE. In general, no consistent patterns indicating that Monensin adversely affect the
incidence of mastitis for any pathogen group were detected.
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7. CONCLUSION
We found no evidence to indicate that Monensin influences the susceptibility of dairy cattle to
clinical mastitis.
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Table 1. Group Codes for Microorganisms or Infection Type
Group
Description
All Cases
Contagious Pathogen (CP)

Environmental Pathogen
(EP)

Staphylococcus spp.,
coagulase-negative
staphylococci (CNS) (SP)
Other Microorganisms
(OT)

Microorganism
Code
ALL
01
03
08
14
04
05
06
07
11
12
02

Undetermined Etiology
(UE)

09
13
15
16
17
50

MS
10
UD
00

Microorganism or
Infection Type
All clinical mastitis cases regardless of culture results
Staphylococcus aureus
Streptococcus agalactiae
Corynebacterium bovis
Mycoplasma spp.
Streptococcus dysgalactiae
Streptococcus spp.
Escherichia coli, Enterobacter spp.
Other Gram-Negatives
Streptococcus uberis
Klebsiella spp.
Staphylococcus spp.

Other Microorganisms
Coagulase-positive Staphylococcus
hyicus
Nocardia spp.
Actinomyces pyogenes
Pseudomonas spp.
Mixed infection
These are microorganisms not
included in EP, SP, CP, or negative.
Missing samples
Contaminated samples
Undetermined samples
Samples where results were classified
as negative

Table 2. List of Five Summary Periods for Clinical Mastitis Cases
Period
05-TC
30-CD
35-DC
45-C7
50-CE
DIM: Days in milk
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Table 3. Generalized Linear Mixed Model for Animal, Quarter, Observation, and Incident Rate

g(ηghij ) = µ + Pg + τ j + Pτ gj + γ h + γτ hj + γβ ghi , where
ηghij = E(X ghij | γ h , γτ hj , and γβ ghi ) for Animal rate,
ηghij = E(Yghij / Q ghij | γ h , γτ hj , and γβ ghi ) for Quarter rate,
ηghij = E(O ghij | γ h , γτ hj , and γβ ghi ) offset by log e (R ghij ) for Observation rate,
ηghij = E(C ghij / R ghij | γ h , γτ hj , and γβ ghi ) for Incident rate,
g(•) = link function (logit or loge) used to linearize conditional mean for GLIMM.
and
µ
Pg
τj
Pτgj

Common mean
Parity effect
Treatment effect

γ

h
γτhj
γβghi

Trial site effect

g

Trial by treatment
interaction

h

Block within trial site
effect

i

Indicates parity
Indicates the hth trial site
Indicates the ith block

j

Indicates the jth treatment
group

Trial site effect

g

Indicates parity

Trial by treatment
interaction

h

Block within trial site
effect

i

Parity by treatment
interaction

Table 4. Linear Mixed Model for Average Case Duration
Y = Xβ + Ζν + ε , where

Xβ = µ + Pg + τ j + Pτ gj , and
Zν = γ h + γτ hj + γβ ghi .
Where
µ
Pg
τj
Pτgj

Common mean
Parity effect
Treatment effect
Parity by treatment
interaction
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h
γτhj
γβghi

j

Indicates the hth trial site
Indicates the ith block
Indicates the jth treatment
group
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Table 5. Summary of Clinical Mastitis Incidents (All Cases) in the Calving 1 to Dry-Off Period
Across All Sites.

Variables
Animal rate
Quarter rate
Observation rate (per 1000 quarter
days at risk)
Incident rate (per 1000 quarter
days at risk)
Average case duration (days )

Monensin Concentration (ppm)
0
8
16
24
0.472
0.200
4.375

0.451
0.197
5.164

0.405
0.175
4.665

0.428
0.185
5.011

0.893

0.865

0.749

0.764

7.34

8.82

7.48

8.12

Note: Monensin non –zero concentration means were not different from controls.

Table 6. Summary of Clinical Mastitis Incidents (All Cases) in the Calving 2 to 203 DIM Period
Across All Sites

Variables
Animal rate
Quarter rate
Observation rate (per 1000 days at
risk)
Incident rate (per 1000 days at risk)
Average case duration, days Multiparous
Average case duration, days Primiparous

Monensin Concentration (ppm)
0
8
16
24
0.589
0.279
13.570

0.521
0.239
15.713

0.490
0.213
13.317

0.478
0.200
7.804*

1.90
14.12

1.716
8.5

1.907
10.06

1.511
10.93

16.78

34.54*

14.36

9.95

* Statistically significant pairwise comparison versus control (P < 0.100).
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